Years of research on brain aging have focused on the question: What causes brain cells to lose communication with each other with age? A new study by the University of California, San Francisco (UCSF), published in Nature Aging, provides a clear answer: a single protein called FTL1 that increases with age and causes the thinning of neural connections. And the big surprise: when you neutralize it, the process reverses.
What is FTL1?
FTL1 (Ferritin Light Chain 1) is a protein responsible for storing iron inside cells. In reasonable amounts it is essential for proper functioning. But the new study shows something disturbing: with age, the levels of FTL1 in the hippocampus (the area of the brain responsible for memory and learning) increase dramatically, and at the same time the connections between brain cells weaken and the person loses memory abilities.
The experiment: they took old mice and made them young, and vice versa
Dr. Soll and Hilde's team at UCSF performed two parallel experiments:
- In old mice: reduced FTL1 levels. In a short time, the brain cells began to rebuild the lost connections, and the mice showed an improvement in the performance of memory tests
- In young mice: increased FTL1 levels. Their brains began to function like those of old mice, with fewer neural connections
The finding that amazed the team: nerve cells engineered to produce FTL1 in excess developed simple neural structures, instead of the complex branches that characterize a healthy cell. That is, FTL1 not only slows down the function, but actually changes the physical shape of the cell.
"This is a real reversal of the deficits. It's much more than just delaying or preventing symptoms," explained Dr. Soule Wilde.
The Secret Connection: Metabolism
The next question was: how does FTL1 damage cells? The answer surprised the researchers. High levels of FTL1 slow down cellular metabolism in the hippocampus. The brain cells do not get the energy they need to maintain their connections, and this loss of connections is exactly what we recognize as cognitive decline.
And here comes the practical step: when the researchers treated the cells with a compound that improves metabolism, the negative effects of FTL1 were completely avoided. That is, the reason is not the iron itself, but the shutdown of the metabolism that the protein carries out.
What does this mean for humans?
It is important to be restrained. The experiments were performed on mice, and it will take some time before a similar treatment is available to humans. But the findings open three promising doors:
- A new drug target: drugs that downregulate FTL1 in a targeted manner could be in development
- Biomarker: FTL1 levels in blood or cerebrospinal fluid may become a test for estimating brain aging
- Boosting metabolism: Nutritional approaches and supplements that improve brain metabolism (like NAD+, creatine, MCT) get a clear theory of why they work
The Broader Context: The Brain Aging Revolution
FTL1 joins a growing list of proteins linked to brain aging, including:
- SASP proteins secreted by senescent cells (zombie cells)
- Growth factors that decrease with age such as BDNF
- TAU and amyloid proteins that accumulate in Alzheimer's
But FTL1 is special in one important way: its reduction alone was enough to reverse cognitive decline in mice. Most of the previous approaches only succeeded in slowing down aging, not turning it back.
Next steps
The UCSF team is already working on:
- Identifying existing drugs that can lower FTL1 (drug repurposing)
- Development of personalized antibodies against FTL1
- Monkey experiments as a last step before humans
If all goes as planned, first human clinical trials could begin in 3-5 years. Until then, the practical insight: maintaining normal brain metabolism through diet, exercise, and quality sleep remains the best defense we have today.
💬 תגובות (0)
היו הראשונים להגיב על המאמר.